CGAS and neoplasm: Thus, expression of the cGAS-STING and DNA-damage marker histone γH2AX in tumor cells could be considered as independent prognostic factors to predict therapy response and clinical outcome, and could be superior to that of traditional markers like immunogenic cell death and T cells number (246).